CorVel (CRVL) Stock Price, News & Analysis

Company Overview

CorVel Corporation provides workers’ compensation and healthcare cost-management services to employers, insurers, and public entities. Its offerings are designed to help clients manage claims, coordinate care, and control healthcare-related costs.

The company’s services include claims administration, medical bill review, provider network access, utilization review, case management, and pharmacy benefit management. CorVel also supports disability and liability claims management.

Founded in 1987, CorVel serves customers across the United States through a combination of technology platforms and service teams. Its work spans the claims process, from initial reporting and medical care coordination to claims review and resolution.

Key Stats

• Today's Range: $85.65 to $87.31
• 50-Day Range: $66.44 to $87.38
• 52-Week Range: $44.83 to $89.76
• Volume: 117,707 shs
• Average Volume: 173,260 shs
• Market Capitalization: $4.31 billion
• P/E Ratio: 36.00
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

CorVel Stock Analysis - MarketRank™

CorVel scored higher than 21% of companies evaluated by MarketBeat, and ranked 793rd out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

CorVel has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

CorVel has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of CorVel is 36.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.41.

Price to Earnings Ratio vs. Sector

The P/E ratio of CorVel is 36.00, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.71.

Price to Book Value per Share Ratio

CorVel has a P/B Ratio of 10.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.55% of the float of CorVel has been sold short.

Short Interest Ratio / Days to Cover

CorVel has a short interest ratio ("days to cover") of 8.12.

Change versus previous month

Short interest in CorVel has recently decreased by 10.92%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

CorVel does not currently pay a dividend.

Dividend Growth

CorVel does not have a long track record of dividend growth.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.34

News Sentiment

CorVel has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for CorVel this week, compared to 2 articles on an average week.

Company Ownership

• Score: 2.0 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, CorVel insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,554,860.00 in company stock.

Percentage Held by Insiders

39.72% of the stock of CorVel is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

51.36% of the stock of CorVel is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 11/03/2026
• Today: 11/14/2026
• Next Earnings (Estimated): 2/02/2027
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:CRVL
• CIK: 874866
• Web: www.corvel.com
• Phone: (503) 222-3144
• Fax: 949-851-1469
• Employees: 5,239
• Year Founded: 1987

Profitability

• EPS (Trailing Twelve Months): $2.38
• Trailing P/E Ratio: 36.00
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $110.34 million
• Net Margins: 12.02%
• Pretax Margin: 15.94%
• Return on Equity: 30.20%
• Return on Assets: 18.06%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.02
• Quick Ratio: 2.02

Sales & Book Value

• Annual Sales: $958.53 million
• Price / Sales: 4.50
• Cash Flow: $2.75 per share
• Price / Cash Flow: 31.14
• Book Value: $8.55 per share
• Price / Book: 10.02

Miscellaneous

• Outstanding Shares: 50,350,000
• Free Float: 30,349,000
• Market Cap: $4.31 billion
• Optionable: Optionable
• Beta: 1.07